Pituitary, Thyroid & Adrenal Disorders
Conference Coverage
Symptoms fail to predict benefit of hormone therapy in older adults with subclinical hypothyroidism
Benefit may be overestimated because previous studies weren’t blinded.
Conference Coverage
In hypoparathyroidism, phosphate, calcium levels may matter
A case-control study showed higher risks of complications in hypoparathyroidism with phosphate and calcium-phosphate levels above the median.
From the Journals
Biotin interference a concern in hormonal assays
Biotinylated assays susceptible to false results.
Conference Coverage
AML risk is doubled in low-risk thyroid cancer patients unnecessarily given radioactive iodine therapy
MADRID - Unnecessary radioactive iodine treatment is associated with nearly twice the risk of developing acute myeloid leukemia (AML) in patients...
From the Journals
Study reveals limits of 4-D CT scanning for parathyroid disease
Four-dimensional computed tomography can miss some types of parathyroid disease.
Conference Coverage
Big changes coming for thyroid cancer staging
How big an impact will new thyroid staging criteria have on the numbers of stage I disease? It’ll be huge.
Conference Coverage
Contralateral nodal thyroid metastases show slow progression
BOSTON – In some thyroid cancers, a small level III contralateral nodal metastasis may be watched safely rather than resected.
Conference Coverage
Thyroid-nodule size boosts serum thyroglobulin’s diagnostic value
Size does matter – at least when it comes to normalizing the serum thyroglobulin level.
Conference Coverage
VIDEO: Less follow-up proposed for low-risk thyroid cancer
BOSTON – Can some patients with good treatment responses safely transition to follow-up monitoring at longer intervals?
Conference Coverage
Is that thyroid nodule malignant?
ESTES PARK, COLO. – Here’s a guideline-backed evaluation strategy for sorting out malignant from benign thyroid nodules.
From the Journals
New trial shows thymectomy benefits myasthenia gravis
New trial moves toward settling thymectomy debate for myasthenia gravis.